Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-005191
Filing Date
2021-11-02
Accepted
2021-11-02 12:29:48
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mosaic_i10q-093021.htm   iXBRL 10-Q 928872
2 CERTIFICATION mosaic_ex3101.htm EX-31.1 8352
3 CERTIFICATION mosaic_ex3102.htm EX-31.2 8446
4 CERTIFICATION mosaic_ex3201.htm EX-32.1 5403
5 CERTIFICATION mosaic_ex3202.htm EX-32.2 5306
  Complete submission text file 0001683168-21-005191.txt   3803791

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cpmv-20210930.xsd EX-101.SCH 29445
7 XBRL CALCULATION FILE cpmv-20210930_cal.xml EX-101.CAL 40782
8 XBRL DEFINITION FILE cpmv-20210930_def.xml EX-101.DEF 127332
9 XBRL LABEL FILE cpmv-20210930_lab.xml EX-101.LAB 234946
10 XBRL PRESENTATION FILE cpmv-20210930_pre.xml EX-101.PRE 196180
11 EXTRACTED XBRL INSTANCE DOCUMENT mosaic_i10q-093021_htm.xml XML 503713
Mailing Address 19881 BROOKHURST STREET, C-245 HUNTINGTON BEACH CA 92646
Business Address 19881 BROOKHURST STREET, C-245 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

EIN.: 841070278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22182 | Film No.: 211370006
SIC: 2836 Biological Products, (No Diagnostic Substances)